Key facts
- Notable investors include Guangdong Wens Investment, Zhiyan Fund.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Womei Biology
- ·The full record, as it builds
Funding rounds
No funding rounds for Womei Biology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Womei Biology
Manufacturer of biopharmaceutical products based in Suzhou, China. The company's range of products includes personalised culture media, bioreactors, and immune adjuvants, biochemical reagents, thereby specializing in pet vaccine manufacturing.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2020
- Website
- suzhouwomei.com/
- Ownership
- Privately Held (backing)
Womei Biology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Womei Biology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Womei Biology in its N-PORT filings yet. We sweep new filings monthly.